Outrageous prices of orphan drugs: a call for collaboration

Lancet. 2018 Sep 1;392(10149):791-794. doi: 10.1016/S0140-6736(18)31069-9. Epub 2018 Jul 20.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cost-Benefit Analysis
  • Drug Costs* / legislation & jurisprudence
  • Drug Discovery / economics*
  • European Union
  • Humans
  • Negotiating
  • Orphan Drug Production / economics*
  • Orphan Drug Production / legislation & jurisprudence
  • Rare Diseases / drug therapy*